These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3439702)

  • 1. Multinuclear NMR study of the metabolism of drug-sensitive and drug-resistant human breast cancer cells.
    Cohen JS; Lyon RC
    Ann N Y Acad Sci; 1987; 508():216-28. PubMed ID: 3439702
    [No Abstract]   [Full Text] [Related]  

  • 2. Information from combined 1H and 31P NMR studies of cell extracts: differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells.
    Kaplan O; van Zijl PC; Cohen JS
    Biochem Biophys Res Commun; 1990 Jun; 169(2):383-90. PubMed ID: 2357212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.
    Neeman M; Degani H
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5585-9. PubMed ID: 2748604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
    Narasimhan TR; Safe S; Williams HJ; Scott AI
    Mol Pharmacol; 1991 Dec; 40(6):1029-35. PubMed ID: 1758438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.
    Lyon RC; Cohen JS; Faustino PJ; Megnin F; Myers CE
    Cancer Res; 1988 Feb; 48(4):870-7. PubMed ID: 3338082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies.
    Kaplan O; Cohen JS
    Breast Cancer Res Treat; 1994; 31(2-3):285-99. PubMed ID: 7881106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
    de Jong S; Mulder NH; de Vries EG; Robillard GT
    Br J Cancer; 1991 Feb; 63(2):205-12. PubMed ID: 1847646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs.
    Hanusovská E; Dovinová I; Tkác I; Novotný L
    Neoplasma; 1998; 45(4):187-97. PubMed ID: 9890660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance.
    Cohen JS
    Mayo Clin Proc; 1988 Dec; 63(12):1199-207. PubMed ID: 3059078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.
    Cohen JS; Lyon RC; Chen C; Faustino PJ; Batist G; Shoemaker M; Rubalcaba E; Cowan KH
    Cancer Res; 1986 Aug; 46(8):4087-90. PubMed ID: 3731076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
    Jaroszewski JW; Kaplan O; Cohen JS
    Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures.
    Harris T; Degani H; Frydman L
    NMR Biomed; 2013 Dec; 26(12):1831-43. PubMed ID: 24115045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS.
    Rivenzon-Segal D; Margalit R; Degani H
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E623-30. PubMed ID: 12217878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced changes in the energetics of human breast cancer cells; 31P- and 13C-NMR studies.
    Neeman M; Eldar H; Rushkin E; Degani H
    Biochim Biophys Acta; 1990 May; 1052(2):255-63. PubMed ID: 2334736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.
    Ting YL; Sherr D; Degani H
    Anticancer Res; 1996; 16(3B):1381-8. PubMed ID: 8694505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
    Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
    Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR.
    Eskey CJ; Koretsky AP; Domach MM; Jain RK
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2646-50. PubMed ID: 8464871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the metabolism of human breast cancer spheroids by NMR.
    Ronen S; Degani H
    Magn Reson Med; 1989 Nov; 12(2):274-81. PubMed ID: 2559291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative metabolomics of breast cancer.
    Yang C; Richardson AD; Smith JW; Osterman A
    Pac Symp Biocomput; 2007; ():181-92. PubMed ID: 17990491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.